About the Authors
- Moon Soo Park
-
Roles Conceptualization, Data curation, Investigation, Validation, Writing – original draft, Writing – review & editing
Affiliation Department of Orthopaedic Surgery, Medical College of Hallym University, Gyeonggi-do, Republic of Korea
- Chang-Nam Kang
-
Roles Conceptualization, Data curation, Investigation, Validation
Affiliation Department of Orthopedic Surgery, Hanyang University College of Medicine, Seoul, Republic of Korea
- Woo-Suk Lee
-
Roles Conceptualization, Data curation, Investigation, Validation
Affiliation Department of Orthopedic Surgery, Gangnam Severance Hospital, Seoul, Republic of Korea
- Ho-Joong Kim
-
Roles Conceptualization, Data curation, Investigation, Validation
Affiliation Spine Center and Department of Orthopaedic Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Gyeonggi-do, Republic of Korea
- Sahnghoon Lee
-
Roles Conceptualization, Data curation, Investigation, Validation
Affiliation Department of Orthopaedic Surgery, Seoul National University, Seoul National University College of Medicine, Seoul, Republic of Korea
- Jin Hwan Kim
-
Roles Conceptualization, Data curation, Investigation, Validation
Affiliation Department of Orthopaedic Surgery, Ilsan Paik Hospital, Inje University College of Medicine, Gyeonggi-do, Republic of Korea
- Sang-Jin Shin
-
Roles Conceptualization, Data curation, Investigation, Validation
Affiliation Department of Orthopaedic Surgery, Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, Republic of Korea
- Seong-Hwan Moon
-
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Validation
* E-mail: SHMOON@yuhs.ac
Affiliation Department of Orthopaedic Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea
Competing Interests
This study was supported by a research fund from Hanmi Pharmaceutical Co., Ltd (grant number HM-IITNAX-001). NAXOZOL(Naproxen, Esomeprazole strontium) was provided by Hanmi Pharmaceutical Co., Ltd. The funder provided support in the form of salaries for authors [MSP, CNK, WSL, HJK, SHL, JHK, SJS, SHM]. NAXOZOL is a combination drug of naproxen and esomeprazole strontium ("esomezol" proved in FDA) as a product marketed in only Korea currently. NAXOZOL was patented in 2013 as it contains esomeprazole strontium developed in Hanmi pharmaceutical company. This does not alter our adherence to PLOS ONE policies on sharing data and materials.